Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Oil & Gas Exploration & Production
Buys113
Sells127
Buy $$158.41M
Sell $$4.23B
Ratio1:26.69
% Change vs. Prior
Ratio +113.1%Value +69.3%
Software - Infrastructure
Buys79
Sells2668
Buy $$17.82M
Sell $$2.64B
Ratio1:148.26
% Change vs. Prior
Ratio -26.7%Value -27.6%
Computer Hardware
Buys2
Sells1967
Buy $$9.90K
Sell $$2.64B
Ratio1:266424.80
% Change vs. Prior
Ratio -80.7%Value +18.2%
Software - Application
Buys163
Sells2013
Buy $$118.31M
Sell $$2.28B
Ratio1:19.25
% Change vs. Prior
Ratio -55.7%Value -23.5%
Biotechnology
Buys412
Sells2632
Buy $$342.37M
Sell $$1.86B
Ratio1:5.44
% Change vs. Prior
Ratio +67.2%Value -42.3%
Semiconductors
Buys107
Sells919
Buy $$11.57M
Sell $$2.06B
Ratio1:178.34
% Change vs. Prior
Ratio +397.6%Value -34.5%
Specialty Retail
Buys71
Sells798
Buy $$138.97M
Sell $$1.38B
Ratio1:9.91
% Change vs. Prior
Ratio +576.9%Value -7.4%
Banks - Regional
Buys362
Sells1029
Buy $$94.12M
Sell $$1.41B
Ratio1:15.03
Waste Management
Buys88
Sells14
Buy $$1.39B
Sell $$4.45M
Ratio312.40:1
Medical - Care Facilities
Buys4
Sells83
Buy $$346.12K
Sell $$1.32B
Ratio1:3804.10
Medical - Instruments & Supplies
Buys16
Sells146
Buy $$2.41M
Sell $$1.22B
Ratio1:506.87
% Change vs. Prior
Ratio -55.0%Value -66.8%
Information Technology Services
Buys40
Sells172
Buy $$21.31M
Sell $$1.19B
Ratio1:55.82
% Change vs. Prior
Ratio +189.0%Value -5.4%
Medical - Diagnostics & Research
Buys16
Sells744
Buy $$3.20M
Sell $$1.14B
Ratio1:354.78
% Change vs. Prior
Ratio -52.1%Value -7.4%
Asset Management
Buys348
Sells241
Buy $$415.83M
Sell $$723.41M
Ratio1:1.74
% Change vs. Prior
Ratio +333.5%Value +2.0%
Apparel - Footwear & Accessories
Buys6
Sells38
Buy $$672.77K
Sell $$1.11B
Ratio1:1650.90

Arcutis Biotherapeutics, Inc. (ARQT)

Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Aug 3, 2026
Sale
Shares
955
Price
$26.12
Total Value
$24.94K
Shares Held After
119,289
% of Holdings
0.8%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Aug 3, 2026
Sale
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Aug 3, 2026
Sale
Shares
81,879
Price
$1.47
Total Value
$120.36K
Shares Held After
44,771
% of Holdings
64.6%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Aug 3, 2026
Sale
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Aug 3, 2026
Sale
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Aug 3, 2026
Sale
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Aug 3, 2026
Sale
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Aug 3, 2026
Sale
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Aug 3, 2026
Sale
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Aug 3, 2026
Sale
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Aug 3, 2026
Sale
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Aug 3, 2026
Sale
Shares
334
Price
$267.99
Total Value
$89.51K
Shares Held After
170,073
% of Holdings
0.2%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Aug 3, 2026
Sale
Shares
317
Price
$267.99
Total Value
$84.95K
Shares Held After
52,115
% of Holdings
0.6%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Aug 3, 2026
Sale
Shares
109
Price
$267.99
Total Value
$29.21K
Shares Held After
245,614
% of Holdings
0.0%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Aug 3, 2026
Sale
Shares
731
Price
$267.99
Total Value
$195.90K
Shares Held After
2,275,394
% of Holdings
0.0%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
128
Price
$268.70
Total Value
$34.39K
Shares Held After
129,019
% of Holdings
0.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
1,233
Price
$267.79
Total Value
$330.18K
Shares Held After
129,147
% of Holdings
0.9%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
192
Price
$265.27
Total Value
$50.93K
Shares Held After
130,380
% of Holdings
0.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
947
Price
$263.94
Total Value
$249.95K
Shares Held After
130,572
% of Holdings
0.7%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
200
Price
$261.49
Total Value
$52.30K
Shares Held After
131,519
% of Holdings
0.2%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
300
Price
$259.98
Total Value
$77.99K
Shares Held After
131,719
% of Holdings
0.2%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Aug 3, 2026
Sale
Shares
410
Price
$267.99
Total Value
$109.88K
Shares Held After
132,019
% of Holdings
0.3%
Aug 3, 2026
Sale
Shares
612
Price
$268.22
Total Value
$164.15K
Shares Held After
99,897
% of Holdings
0.6%
Aug 3, 2026
Sale
Shares
296
Price
$267.08
Total Value
$79.06K
Shares Held After
100,509
% of Holdings
0.3%
Aug 3, 2026
Sale
Shares
80
Price
$265.27
Total Value
$21.22K
Shares Held After
100,805
% of Holdings
0.1%
Aug 3, 2026
Sale
Shares
676
Price
$263.86
Total Value
$178.37K
Shares Held After
100,885
% of Holdings
0.7%
Aug 3, 2026
Sale
Shares
70
Price
$261.02
Total Value
$18.27K
Shares Held After
101,561
% of Holdings
0.1%
Aug 3, 2026
Sale
Shares
160
Price
$259.98
Total Value
$41.60K
Shares Held After
101,631
% of Holdings
0.2%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Aug 3, 2026
Sale
Shares
295
Price
$267.99
Total Value
$79.06K
Shares Held After
183,774
% of Holdings
0.2%
Aug 3, 2026
Sale
Shares
1,182
Price
$267.99
Total Value
$316.76K
Shares Held After
101,791
% of Holdings
1.1%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
6,250
Price
$137.37
Total Value
$858.56K
Shares Held After
162,500
% of Holdings
3.7%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
6,250
Price
$137.37
Total Value
$858.56K
Shares Held After
168,750
% of Holdings
3.6%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
82
Price
$139.20
Total Value
$11.41K
Shares Held After
0
% of Holdings
100.0%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
760
Price
$138.09
Total Value
$104.95K
Shares Held After
82
% of Holdings
90.3%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
3,125
Price
$137.25
Total Value
$428.89K
Shares Held After
842
% of Holdings
78.8%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
1,983
Price
$136.42
Total Value
$270.53K
Shares Held After
3,967
% of Holdings
33.3%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
43
Price
$135.41
Total Value
$5.82K
Shares Held After
5,950
% of Holdings
0.7%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
173
Price
$133.81
Total Value
$23.15K
Shares Held After
5,993
% of Holdings
2.8%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
84
Price
$133.01
Total Value
$11.17K
Shares Held After
6,166
% of Holdings
1.3%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
82
Price
$139.21
Total Value
$11.42K
Shares Held After
6,250
% of Holdings
1.3%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
762
Price
$138.09
Total Value
$105.22K
Shares Held After
6,332
% of Holdings
10.7%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
3,124
Price
$137.25
Total Value
$428.75K
Shares Held After
7,094
% of Holdings
30.6%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
1,981
Price
$136.42
Total Value
$270.26K
Shares Held After
10,218
% of Holdings
16.2%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
44
Price
$135.41
Total Value
$5.96K
Shares Held After
12,199
% of Holdings
0.4%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
173
Price
$133.81
Total Value
$23.15K
Shares Held After
12,243
% of Holdings
1.4%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
84
Price
$133.00
Total Value
$11.17K
Shares Held After
12,416
% of Holdings
0.7%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
267
Price
$139.21
Total Value
$37.17K
Shares Held After
12,500
% of Holdings
2.1%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
2,431
Price
$138.09
Total Value
$335.69K
Shares Held After
12,767
% of Holdings
16.0%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
9,989
Price
$137.25
Total Value
$1.37M
Shares Held After
15,198
% of Holdings
39.7%

BillionToOne, Inc. (BLLN)

Atay Oguzhan — Director
Aug 3, 2026
Sale
Shares
6,354
Price
$136.42
Total Value
$866.84K
Shares Held After
25,187
% of Holdings
20.1%
Version: v26.10.12